240 related articles for article (PubMed ID: 30295722)
1. Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease.
Buttó LF; Jia LG; Arseneau KO; Tamagawa H; Rodriguez-Palacios A; Li Z; De Salvo C; Pizarro TT; Bamias G; Cominelli F
Inflamm Bowel Dis; 2019 Jan; 25(1):14-26. PubMed ID: 30295722
[TBL] [Abstract][Full Text] [Related]
2. Death Receptor 3 Signaling Controls the Balance between Regulatory and Effector Lymphocytes in SAMP1/YitFc Mice with Crohn's Disease-Like Ileitis.
Li Z; Buttó LF; Buela KA; Jia LG; Lam M; Ward JD; Pizarro TT; Cominelli F
Front Immunol; 2018; 9():362. PubMed ID: 29545797
[TBL] [Abstract][Full Text] [Related]
3. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
Valatas V; Kolios G; Bamias G
Front Immunol; 2019; 10():583. PubMed ID: 30972074
[TBL] [Abstract][Full Text] [Related]
4. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis.
Bamias G; Mishina M; Nyce M; Ross WG; Kollias G; Rivera-Nieves J; Pizarro TT; Cominelli F
Proc Natl Acad Sci U S A; 2006 May; 103(22):8441-6. PubMed ID: 16698931
[TBL] [Abstract][Full Text] [Related]
5. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
Siakavellas SI; Bamias G
Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
[TBL] [Abstract][Full Text] [Related]
6. Semisynthetic diet ameliorates Crohn's disease-like ileitis in TNFΔARE/WT mice through antigen-independent mechanisms of gluten.
Wagner SJ; Schmidt A; Effenberger MJ; Gruber L; Danier J; Haller D
Inflamm Bowel Dis; 2013 May; 19(6):1285-94. PubMed ID: 23567784
[TBL] [Abstract][Full Text] [Related]
7. Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation.
Bamias G; Martin C; Mishina M; Ross WG; Rivera-Nieves J; Marini M; Cominelli F
Gastroenterology; 2005 Mar; 128(3):654-66. PubMed ID: 15765401
[TBL] [Abstract][Full Text] [Related]
8. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes.
Papadakis KA; Zhu D; Prehn JL; Landers C; Avanesyan A; Lafkas G; Targan SR
J Immunol; 2005 Apr; 174(8):4985-90. PubMed ID: 15814728
[TBL] [Abstract][Full Text] [Related]
9. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection.
Jia LG; Bamias G; Arseneau KO; Burkly LC; Wang EC; Gruszka D; Pizarro TT; Cominelli F
J Immunol; 2016 Jul; 197(1):377-86. PubMed ID: 27233964
[TBL] [Abstract][Full Text] [Related]
10. The role of TL1A and DR3 in autoimmune and inflammatory diseases.
Aiba Y; Nakamura M
Mediators Inflamm; 2013; 2013():258164. PubMed ID: 24453414
[TBL] [Abstract][Full Text] [Related]
11. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
[TBL] [Abstract][Full Text] [Related]
12. The tumor necrosis factor-like cytokine 1A/death receptor 3 cytokine system in intestinal inflammation.
Bamias G; Jia LG; Cominelli F
Curr Opin Gastroenterol; 2013 Nov; 29(6):597-602. PubMed ID: 24100723
[TBL] [Abstract][Full Text] [Related]
13. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease-associated mucosal factors regulate the expression of TNF-like cytokine 1A and its receptors in primary subepithelial intestinal myofibroblasts and intestinal epithelial cells.
Bamias G; Filidou E; Goukos D; Valatas V; Arvanitidis K; Panagopoulou M; Kouklakis G; Daikos GL; Ladas SD; Kolios G
Transl Res; 2017 Feb; 180():118-130.e2. PubMed ID: 27665176
[TBL] [Abstract][Full Text] [Related]
15. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
Meylan F; Richard AC; Siegel RM
Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
[TBL] [Abstract][Full Text] [Related]
16. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
[TBL] [Abstract][Full Text] [Related]
17. The death receptor 3/TL1A pathway is essential for efficient development of antiviral CD4⁺ and CD8⁺ T-cell immunity.
Twohig JP; Marsden M; Cuff SM; Ferdinand JR; Gallimore AM; Perks WV; Al-Shamkhani A; Humphreys IR; Wang EC
FASEB J; 2012 Aug; 26(8):3575-86. PubMed ID: 22593543
[TBL] [Abstract][Full Text] [Related]
18. TL1A/DR3 signaling regulates the generation of pathogenic Th9 cells in experimental inflammatory bowel disease.
Menghini P; Butto L; Gomez-Nguyen A; Aladyshkina N; Buela KA; Osme A; Chan R; Bamias G; Pizarro TT; Cominelli F
bioRxiv; 2024 Feb; ():. PubMed ID: 38405912
[TBL] [Abstract][Full Text] [Related]
19. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease.
Bamias G; Martin C; Marini M; Hoang S; Mishina M; Ross WG; Sachedina MA; Friel CM; Mize J; Bickston SJ; Pizarro TT; Wei P; Cominelli F
J Immunol; 2003 Nov; 171(9):4868-74. PubMed ID: 14568967
[TBL] [Abstract][Full Text] [Related]
20. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.
Meylan F; Davidson TS; Kahle E; Kinder M; Acharya K; Jankovic D; Bundoc V; Hodges M; Shevach EM; Keane-Myers A; Wang EC; Siegel RM
Immunity; 2008 Jul; 29(1):79-89. PubMed ID: 18571443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
